Global Antisense and RNAi Therapeutics Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI134555
- March 20, 2019
- Global
- 91 pages
- QY Market Research
The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology.
The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the near future.
The global Antisense and RNAi Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antisense and RNAi Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antisense and RNAi Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Tekmira Pharmaceuticals
Arbutus Biopharma
Alnylam Pharmaceuticals
Antisense Therapeutics
Silence Therapeutics
Isis Pharmaceuticals
Sirnaomics
Santaris
Roche
Segment by Regions
North America
Europe
China
Japan
Segment by Type
RNA Interference
Antisense RNA
Segment by Application
Hospital
Clinic
Table of Contents
Executive Summary
1 Antisense and RNAi Therapeutics Market Overview
1.1 Product Overview and Scope of Antisense and RNAi Therapeutics
1.2 Antisense and RNAi Therapeutics Segment by Type
1.2.1 Global Antisense and RNAi Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 RNA Interference
1.2.3 Antisense RNA
1.3 Antisense and RNAi Therapeutics Segment by Application
1.3.1 Antisense and RNAi Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Antisense and RNAi Therapeutics Market by Region
1.4.1 Global Antisense and RNAi Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Antisense and RNAi Therapeutics Market Size
1.5.1 Global Antisense and RNAi Therapeutics Revenue (2014-2025)
1.5.2 Global Antisense and RNAi Therapeutics Production (2014-2025)
2 Global Antisense and RNAi Therapeutics Market Competition by Manufacturers
2.1 Global Antisense and RNAi Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Antisense and RNAi Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Antisense and RNAi Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Antisense and RNAi Therapeutics Production Sites, Area Served, Product Types
2.5 Antisense and RNAi Therapeutics Market Competitive Situation and Trends
2.5.1 Antisense and RNAi Therapeutics Market Concentration Rate
2.5.2 Antisense and RNAi Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Antisense and RNAi Therapeutics Production Market Share by Regions
3.1 Global Antisense and RNAi Therapeutics Production Market Share by Regions
3.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Regions (2014-2019)
3.3 Global Antisense and RNAi Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Antisense and RNAi Therapeutics Production
3.4.1 North America Antisense and RNAi Therapeutics ...
| read more...
Related Reports
Global Antiseptic Mouthwash Market 2020 (Includes Business Impact of COVID-19)
Published : 29, April
Published : 29, April